Aids 2026 Upd May 2026

In Eastern Europe and Central Asia, infection rates are rising —not falling. Why? Geopolitics. The disruption of global supply chains (exacerbated by the economic volatility of the mid-2020s) has pushed HIV treatment to the bottom of the national priority list.

Suggested SEO Tags: AIDS 2026, HIV Cure Update, Long Acting PrEP, Global Health Equity, HIV and Aging, CRISPR HIV, U=U. aids 2026

In 2026, the largest cohort of people living with HIV in North America and Western Europe are over 55 years old. In Eastern Europe and Central Asia, infection rates

You have heard the rumors about the CRISPR cure. In 2026, we are still waiting for the "London Patient" miracle to become a pharmacy product. Gene editing is expensive ($2 million per patient). It works. But it isn't scalable. The disruption of global supply chains (exacerbated by

The problem isn't dying of AIDS in 2026. It's living with HIV and facing a frail body at 60. Geriatric HIV care is the specialty no one trained for, and we are scrambling to catch up.

AIDS 2026: The Last Mile of the Epidemic or a Warning from the Future?